Vivatides Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $54M

  • Investors
  • 4

Vivatides Therapeutics General Information

Description

Developer of ribonucleic acid (RNA) therapeutics intended to benefit patients' lives. The company's research focuses on antibody conjugates that allow for more targeted delivery of therapeutic payloads, enabling physicians to prescribe more effective treatments to patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Woburn, MA 01813
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Woburn, MA 01813
  • United States

Vivatides Therapeutics Timeline

2026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivatides Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 10-Apr-2026 $54M Completed Startup
1. Seed Round 12-Feb-2025 Completed Startup
To view Vivatides Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Vivatides Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vivatides Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Highlight Capital Venture Capital Minority
TF Capital Venture Capital Minority
Apricot Capital (Shanghai) Venture Capital Minority
Qiming Venture Partners Venture Capital Minority
To view Vivatides Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Vivatides Therapeutics FAQs

  • When was Vivatides Therapeutics founded?

    Vivatides Therapeutics was founded in 2025.

  • Where is Vivatides Therapeutics headquartered?

    Vivatides Therapeutics is headquartered in Woburn, MA.

  • What is the size of Vivatides Therapeutics?

    Vivatides Therapeutics has 4 total employees.

  • What industry is Vivatides Therapeutics in?

    Vivatides Therapeutics’s primary industry is Drug Discovery.

  • Is Vivatides Therapeutics a private or public company?

    Vivatides Therapeutics is a Private company.

  • What is Vivatides Therapeutics’s current revenue?

    The current revenue for Vivatides Therapeutics is .

  • How much funding has Vivatides Therapeutics raised over time?

    Vivatides Therapeutics has raised $64M.

  • Who are Vivatides Therapeutics’s investors?

    Highlight Capital, TF Capital, Apricot Capital (Shanghai), and Qiming Venture Partners have invested in Vivatides Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process